Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 18.6 (18.5, 18.7) N/A 70,394 falling falling trend -1.3 (-1.5, -0.9)
Alabama 6 15.1 (14.7, 15.6) 45 (43, 48) 917 falling falling trend -0.6 (-1.0, -0.2)
Alaska 6 17.9 (16.5, 19.4) 32 (9, 43) 129 stable stable trend -1.1 (-2.1, 0.0)
Arizona 6 14.6 (14.3, 15.0) 47 (44, 49) 1,312 falling falling trend -0.8 (-1.2, -0.3)
Arkansas 6 18.2 (17.6, 18.8) 27 (15, 37) 678 stable stable trend 0.1 (-0.5, 0.7)
California 7 17.8 (17.6, 18.0) 33 (27, 36) 7,755 falling falling trend -0.8 (-1.5, -0.5)
Colorado 6 16.6 (16.1, 17.0) 41 (36, 43) 1,027 falling falling trend -1.0 (-1.4, -0.6)
Connecticut 7 20.5 (19.9, 21.1) 8 (3, 13) 940 stable stable trend -0.5 (-2.8, 0.0)
Delaware 6 17.7 (16.6, 18.8) 34 (14, 43) 224 falling falling trend -3.8 (-10.4, -1.0)
District of Columbia 6 14.6 (13.3, 15.9) 48 (41, 49) 101 falling falling trend -1.7 (-2.5, -1.0)
Florida 6 21.5 (21.3, 21.7) 2 (1, 5) 6,386 falling falling trend -3.6 (-6.1, -2.0)
Georgia 7 17.5 (17.1, 17.8) 36 (28, 39) 1,987 stable stable trend -2.0 (-4.1, 0.2)
Hawaii 7 14.9 (14.1, 15.8) 46 (42, 49) 278 falling falling trend -2.7 (-4.5, -1.6)
Idaho 7 19.1 (18.2, 19.9) 15 (8, 32) 388 stable stable trend -0.1 (-0.6, 0.4)
Illinois 7 18.9 (18.6, 19.2) 18 (12, 26) 2,842 falling falling trend -0.3 (-1.6, -0.1)
Iowa 7 21.2 (20.5, 21.8) 4 (1, 9) 828 stable stable trend -0.7 (-2.1, 0.0)
Kansas 6 18.9 (18.2, 19.5) 20 (10, 31) 644 stable stable trend -0.5 (-1.0, 0.1)
Kentucky 7 19.5 (19.0, 20.1) 11 (8, 22) 1,061 falling falling trend -0.8 (-3.8, -0.2)
Louisiana 7 18.5 (18.0, 19.1) 24 (13, 33) 995 falling falling trend -0.8 (-2.4, -0.3)
Maine 6 20.0 (19.1, 21.0) 9 (3, 23) 390 stable stable trend -0.5 (-1.2, 0.2)
Maryland 6 17.9 (17.4, 18.3) 30 (23, 38) 1,274 stable stable trend 0.0 (-0.6, 0.7)
Massachusetts 7 18.9 (18.5, 19.3) 19 (11, 28) 1,608 falling falling trend -0.4 (-1.0, -0.2)
Michigan 6 18.6 (18.3, 19.0) 22 (14, 29) 2,330 falling falling trend -0.9 (-1.3, -0.4)
Minnesota 6 21.9 (21.4, 22.4) 1 (1, 5) 1,474 stable stable trend 0.2 (-0.4, 0.8)
Mississippi 6 16.3 (15.7, 16.9) 42 (36, 45) 571 stable stable trend -0.1 (-2.1, 1.9)
Missouri 6 18.4 (18.0, 18.9) 26 (15, 32) 1,409 stable stable trend -0.2 (-0.5, 0.1)
Montana 6 17.9 (16.9, 19.0) 31 (12, 42) 250 stable stable trend -0.6 (-1.2, 0.1)
Nebraska 6 19.3 (18.5, 20.2) 14 (7, 29) 438 stable stable trend -0.4 (-0.9, 0.2)
New Hampshire 6 20.8 (19.8, 21.8) 6 (1, 14) 375 stable stable trend -0.1 (-0.9, 0.8)
New Jersey 7 21.3 (20.9, 21.7) 3 (1, 7) 2,323 stable stable trend 0.0 (-0.2, 0.2)
New Mexico 7 14.3 (13.6, 15.0) 49 (44, 49) 376 falling falling trend -0.9 (-4.0, -0.2)
New York 7 21.0 (20.7, 21.3) 5 (3, 8) 5,006 stable stable trend -0.3 (-0.8, 0.0)
North Carolina 6 17.6 (17.3, 17.9) 35 (27, 39) 2,196 stable stable trend 0.2 (-1.0, 2.1)
North Dakota 6 18.7 (17.4, 20.0) 21 (7, 40) 163 stable stable trend -0.4 (-1.4, 0.7)
Ohio 6 19.0 (18.6, 19.3) 16 (12, 26) 2,775 stable stable trend -0.2 (-0.4, 0.1)
Oklahoma 6 17.0 (16.5, 17.6) 39 (30, 43) 784 falling falling trend -1.0 (-1.4, -0.6)
Oregon 6 18.0 (17.5, 18.5) 29 (19, 38) 944 falling falling trend -0.7 (-1.2, -0.2)
Pennsylvania 6 19.8 (19.5, 20.2) 10 (8, 15) 3,340 falling falling trend -1.9 (-3.1, -1.0)
Puerto Rico 6 13.9 (13.4, 14.5) N/A 560 stable stable trend -0.9 (-5.0, 3.4)
Rhode Island 6 18.6 (17.6, 19.7) 23 (9, 39) 251 stable stable trend -0.3 (-1.2, 0.6)
South Carolina 6 15.6 (15.1, 16.0) 44 (42, 47) 994 falling falling trend -3.3 (-6.2, -0.8)
South Dakota 6 19.3 (18.1, 20.6) 13 (4, 36) 206 stable stable trend -0.3 (-1.0, 0.5)
Tennessee 6 17.4 (17.0, 17.8) 37 (28, 40) 1,434 stable stable trend -0.2 (-2.3, 1.6)
Texas 7 17.2 (17.0, 17.4) 38 (34, 40) 4,928 stable stable trend -0.1 (-0.9, 0.4)
Utah 7 18.1 (17.4, 18.8) 28 (14, 39) 507 falling falling trend -1.1 (-2.6, -0.3)
Vermont 6 18.5 (17.2, 19.9) 25 (7, 41) 161 stable stable trend 0.3 (-6.1, 5.0)
Virginia 6 16.6 (16.3, 17.0) 40 (37, 43) 1,653 falling falling trend -0.7 (-1.3, -0.4)
Washington 5 18.9 (18.5, 19.4) 17 (11, 27) 1,648 falling falling trend -1.1 (-1.3, -0.9)
West Virginia 6 19.5 (18.7, 20.3) 12 (6, 27) 490 stable stable trend -0.1 (-0.6, 0.4)
Wisconsin 6 20.7 (20.2, 21.2) 7 (3, 10) 1,504 stable stable trend 0.0 (-0.7, 0.2)
Wyoming 6 15.9 (14.5, 17.3) 43 (29, 49) 111 stable stable trend -0.6 (-1.5, 0.3)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 02/29/2024 2:29 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top